circulating insulin-like growth factor igf peptides prostate cancer risk systematic review meta-analysis abstract insulin-like growth factors igf-i igf-ii binding proteins igfbp num play key role cell proliferation differentiation apoptosis suggesting involvement carcinogenesis epidemiological studies show associations igfs prostate cancer searched published literature studies relating levels igfs igfbps prostate cancer performed random effects meta-analysis calculate summary odds ratios number studies prostate cancer cases included meta-analysis num num igf-i num igf-ii num igfbp num num igfbp num num igfbp num num num igf num igfbp num ratio pooled odds ratios num confidence intervals standard deviation increase peptide igf-i num num num igf-ii num num num igfbp num num num num igfbp num num num num igfbp num num num num igfi:igfbp num ratio num num num exposures substantial heterogeneity num num partly explained study design magnitude associations smaller prospective versus retrospective studies igfbp num inverse association prostate cancer risk retrospective prospective studies weak evidence associations igf-i igfbp num prostate cancer stronger advanced disease meta-analysis confirms raised circulating lgf-i positively prostate cancer risk associations igfbp num prostate cancer inconsistent evidence role igf-ii igfbp num igfbp num prostate cancer risk 
